Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Tina Stow

Tina Stow Tina Stow previously served as Vice President of Communications at PhRMA. Prior to joining PhRMA in 2014, she spent more than a dozen years in corporate and agency communications and public affairs roles. A D.C. transplant via North Carolina and Georgia, Tina likes to travel, make the rounds to D.C.’s new restaurants, dote on her rescue labradoodle (Chloe), and complain about winter.

Recent Posts

PhRMA Webcast to Examine Progress and Promise of Alzheimer’s Research

By Tina Stow  |    July 9, 2015
Alzheimer’s disease has a devastating impact on patients, their loved ones and the caregivers who help them navigate their daily lives. It’s a particularly cruel disease – one that is especially...   Read More

3 Reasons Innovation Depends On Strong IP Protections in the TPP

By Tina Stow  |    June 16, 2015
As Congress continues to debate Trade Promotion Authority (TPA), it is important to keep in mind why the Trans-Pacific Partnership (TPP) – the largest trade deal in history – can and should help...   Read More

ICYMI: Next Generation Cures

By Tina Stow  |    May 15, 2015
On Tuesday, May 12th, PhRMA and The Hill convened a symposium with legislators and leading health care experts on “Next Generation Cures.” Speakers and panelists focused on how all health care...   Read More

ICYMI: A Broad Coalition of Stakeholders Continue to Raise Concerns about Patent Litigation Reform

By Tina Stow  |    April 30, 2015
As we’ve shared here, here and here on the Catalyst, Congress is currently considering new patent litigation reform legislation. The Innovation Act (H.R. 9) will soon be marked up in the U.S. House...   Read More

Week in Review: The Latest from PhRMA

By Tina Stow  |    April 17, 2015
Spending on Medicines: The Big Picture – PhRMA’s new video explains how high generic utilization rates, competition among brand-name medicines and aggressive tactics by insurers and pharmacy benefit ...   Read More

PhRMA & LLS: More than 240 Medicines in Development for Blood Cancers

By Tina Stow  |    April 10, 2015
It’s hard to believe, but – this year alone – more than 162,000 Americans will be diagnosed with a form of blood cancer, such as leukemia, lymphoma or myeloma. Fortunately, science has advanced...   Read More

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

By Tina Stow  |    March 26, 2015
“Whether it’s our family, our friends, all of us are potentially patients one day.” In a single sentence, Dr. Anthony Coyle, senior vice president and chief scientific officer at Pfizer’s Centers for...   Read More

World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

By Tina Stow  |    February 4, 2015
Today is World Cancer Day, and 2015’s “Not beyond us” theme highlights an incredibly important message: we’re making tremendous advances in the fight against cancer and continued progress means a...   Read More

New Evidence of Discrimination in Essential Health Benefit Plans

By Tina Stow  |    January 30, 2015
While the Affordable Care Act (ACA) expanded access to health insurance coverage for millions, a new study from the Harvard T.H. Chan School of Public Health reveals that insurers may be...   Read More

Get Involved to Protect Women’s Health During Cervical Health Awareness Month

By Tina Stow  |    January 30, 2015
Many people likely don’t realize that the human papillomavirus, or HPV, is one of the most prevalent sexually transmitted diseases in the United States. This means 79 million Americans, both men and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates